Cargando…
Deubiquitinases in hematological malignancies
Deubiquitinases (DUBs) are enzymes that control the stability, interactions or localization of most cellular proteins by removing their ubiquitin modification. In recent years, some DUBs, such as USP7, USP9X and USP10, have been identified as promising therapeutic targets in hematological malignanci...
Autores principales: | Lei, Hu, Wang, Jiaqi, Hu, Jiacheng, Zhu, Qian, Wu, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401176/ https://www.ncbi.nlm.nih.gov/pubmed/34454635 http://dx.doi.org/10.1186/s40364-021-00320-w |
Ejemplares similares
Ejemplares similares
-
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
por: Li, Jinxin, et al.
Publicado: (2023) -
Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
por: Zhang, Shilong, et al.
Publicado: (2023) -
Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
por: LIU, Jiaqi, et al.
Publicado: (2022) -
Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016) -
Deubiquitinases in cancer
por: Wei, Rongbin, et al.
Publicado: (2015)